Inactive ingredients in medications-called excipients-may not be as harmless as once thought. Research shows some can affect biological targets, alter drug absorption, and trigger reactions in sensitive individuals.
Category: Medications - Page 2
Boxed warnings, or black box warnings, are the FDA's strongest safety alerts for prescription drugs. Learn what they mean, which drugs carry them, how to respond, and what to ask your doctor to stay safe.
Landmark court decisions like Amgen v. Sanofi and Allergan v. Teva are reshaping how generic drugs enter the market, delaying access and raising prices. Learn how patent law affects what you pay for medicine.
Ondansetron effectively treats nausea but carries a risk of QT prolongation, which can lead to life-threatening heart rhythms. Learn who's at risk, safe dosing guidelines, and safer alternatives.
Direct-to-consumer pharmacies can save you hundreds on expensive generics-but not always. Learn where cash pay beats insurance, which sites offer the best prices, and how to shop smart without wasting time.
Learn how to calmly and effectively discuss FDA drug safety alerts with your doctor - without panic or confusion. Get the right questions to ask, what to bring to your appointment, and how to avoid common mistakes.
Learn what BID, TID, and PRN mean on your prescription label, why they’re still used, and how to avoid dangerous mistakes. Get clear, practical tips to take your meds safely.
Learn how RFID, eMAR systems, and mobile apps help hospitals, EMS, and families track medication expiration dates automatically - reducing waste, improving safety, and saving time.
Learn how to spot look-alike drug names on prescription labels to prevent dangerous medication errors. Discover tall man lettering, safety tools, and what you can do to stay safe.
Patent law in pharmaceuticals balances innovation with access by granting exclusive rights to drug makers while enabling generics to enter after patent expiration. The Hatch-Waxman Act created this system, saving billions but facing abuse through patent thickets and pay-for-delay deals.